Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Financing Activities: 2020-2024

Historic Cash from Financing Activities for Therapeutics (LENZ) over the last 5 years, with Dec 2024 value amounting to $199.0 million.

  • Therapeutics' Cash from Financing Activities fell 883.20% to -$1.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $80.9 million, marking a year-over-year change of. This contributed to the annual value of $199.0 million for FY2024, which is 146.59% up from last year.
  • As of FY2024, Therapeutics' Cash from Financing Activities stood at $199.0 million, which was up 146.59% from $80.7 million recorded in FY2023.
  • In the past 5 years, Therapeutics' Cash from Financing Activities ranged from a high of $417.5 million in FY2021 and a low of $597,000 during FY2022.
  • Moreover, its 3-year median value for Cash from Financing Activities was $80.7 million (2023), whereas its average is $93.4 million.
  • Per our database at Business Quant, Therapeutics' Cash from Financing Activities plummeted by 99.86% in 2022 and then soared by 13,417.59% in 2023.
  • Therapeutics' Cash from Financing Activities (Yearly) stood at $30.1 million in 2020, then skyrocketed by 1,287.99% to $417.5 million in 2021, then tumbled by 99.86% to $597,000 in 2022, then surged by 13,417.59% to $80.7 million in 2023, then surged by 146.59% to $199.0 million in 2024.